• Skip to content

Mobius Therapeutics

Dedicated to perioperative pharmaceuticals for ophthalmology

  • Home
  • Products
    • Product Lineup
    • Drug Safety
    • Peri-Operative Resource Center
  • Contact Us
  • Place An Order
  • News
    • Press Releases
    • Mobius Newsletter
  • About Us
    • The Mobius Team
    • Company Profile
    • Corporate Responsibility
    • Terms of Use
    • Privacy Policy

Peri-Operative Ophthalmology

Legislative   Mitomycin    Anesthetics

Legislative (DQSA, USP)

DQSA Law

DQSA Law

Read the Drug Quality and Security Act (DQSA) law which grants the FDA regulatory authority over compounded drugs.  See the law

DQSA Webinar

DQSA Webinar

Mobius teamed up with ASORN to present an informative webinar discussing DQSA and how it affects your business, featuring two industry experts answering questions and providing important details about the law.   Watch the  DQSA Compliance Webinar

Pharmacy Risk

DQSA Risks of Pharmacy Compounding

This important document thoroughly discusses the risks associated with compounded drugs.   Learn more

DQSA Law

USP Guidance

Hazardous drugs – handling in healthcare settings. Read about the important requirements for handling hazardous drugs to protect patient, personnel and environment.  Read More

NIOSH Alert

USP 800 NIOSH Alert

Both traditional medications and bioengineered drugs can be hazardous to health care workers who must handle them.  This NIOSH Alert will help make workers and employers more aware of these hazards and provide the tools for preventing exposures.  Read More

Mitomycin

ASORN Wall Chart

Top tips for safe handling, use, and disposal of Ophthalmic Mitomycin-C.  Provide by American Society of Ophthalmic Registered Nurses(ASORN) for educational purposes.  Download it

ASORN MMC Guide

ASORN MMC Guide

Independent authors’ guidelines for the safe use and handling of mitomycin C in ophthalmic practices.  Learn more

Anesthetics

IJO Report

IJO Article – Hyaluronidase Clinical Trial

Results of a clinical trial investigating the effect of hyaluronidase usage on the quality of sub-Tenon’s anesthesia for phacoemulsification.  Read the article.

WMT-004 Rev 01/2018

© 2018 · Mobius Therapeutics